Form EFFECT Nasus Pharma Ltd
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 20, 2026 |
| Accession Number: | 0001493152-26-039052 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hustle Culture is Over: Two-Time Founder Kelly Ehlers Rewrites the Rules for Women in New Book, Nice Girls Win
- Equativ Brings ChatGPT Ads to Brands as Advertising Partner
- The Trillion-Dollar Buildout Lands in Las Vegas: Yotta 2026 Opens Next Week
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
